Idiopathic Pulmonary Fibrosis Market Share

Market Share of Idiopathic Pulmonary Fibrosis Industry

The idiopathic pulmonary fibrosis market is moderately competitive in nature, and there are several local and international companies in this market. Some of the key market players in the market are Afferent Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., F. Hoffmann-La Roche Ltd, FibroGen, Genentech USA Inc., Jubilant Cadista, Merck & Co. Inc., and Prometic Life Sciences.

Idiopathic Pulmonary Fibrosis Market Leaders

1. Cipla Inc.

2. Boehringer Ingelheim International GmbH

3. F. Hoffmann-La Roche Ltd

4. FibroGen, Inc.

5. Horizon Therapeutics plc

*Disclaimer: Major Players sorted in no particular order